Diebold Nixdorf DBD
$51.86 +$1.59 (+3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.86 0.00%
Open$49.97
Prev close$50.27
Day range$49.92 – $52.07
Volume515.3K
Market cap$1.74B
P/E (TTM)24.6
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$994.30M+5.2% YoY
Operating profit$69.70M-16.7% YoY
Net profit$7.10M-83.0% YoY
Diluted EPS$0.19-82.9% YoY
Free cash flow-$60.30M-346.1% YoY
Operating cash flow-$47.40M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin25.0%
Operating margin6.2%
Net margin2.0%
Return on equity7.5%
Return on assets2.1%
Return on invested capital6.7%
Current ratio1.27
Liabilities / assets74.2%
Cash & investments$184.90M
Total debt$949.30M
Net cash (debt)-$764.40M
Free cash flow / sales3.2%
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $994.30M | $930.80M | $891.80M | $3.81B | $1.10B |
| Total Operating Revenue | $994.30M | $930.80M | $891.80M | $3.81B | $1.10B |
| Cost of Revenue | $747.10M | $691.20M | $678.70M | $2.84B | $824.40M |
| Gross Profit | $247.20M | $239.60M | $213.10M | $961.20M | $279.80M |
| Operating Expense | $177.50M | $167.70M | $168.50M | $719.20M | $221.50M |
| Selling and Admin Expenses | $141.50M | $147.80M | $145.30M | $632.50M | $198.60M |
| Research & Development | $19.80M | $20.50M | $22.10M | $86.70M | $21.40M |
| Other Operating Expenses | $16.20M | -$600,000.00 | $1.10M | – | – |
| Operating Profit | $69.70M | $71.90M | $44.60M | $242.00M | $58.30M |
| Net Non-Operating Interest Income (Expense) | -$21.10M | -$22.00M | -$20.40M | -$76.80M | -$17.80M |
| Non-Operating Interest Income | $5.60M | $2.10M | $2.90M | $8.90M | $2.80M |
| Non-Operating Interest Expense | $26.70M | $24.10M | $23.30M | $85.70M | $20.60M |
| Other Income (Expense) | -$33.30M | -$13.60M | -$11.80M | -$40.10M | $22.30M |
| Gain on Sale of Security | $500,000.00 | -$2.40M | -$2.40M | -$44.10M | -$2.60M |
| Special Income (Charges) | -$30.90M | -$14.50M | -$11.90M | $0.00 | $24.10M |
| -Less:Restructuring and Mergern & Acquisition | $30.90M | $14.50M | $11.90M | $0.00 | -$24.10M |
| Other Non-Operating Income (Expenses) | -$2.90M | $3.30M | $2.50M | $4.00M | $800,000.00 |
| Pretax Profit | $15.30M | $36.30M | $12.40M | $125.10M | $62.80M |
| Tax | $5.60M | $19.20M | $5.70M | $24.10M | $11.90M |
| $2.60M | $900,000.00 | $1.20M | $3.50M | $400,000.00 | |
| Net Profit | $7.10M | $16.20M | $5.50M | $97.50M | $50.50M |
| Profit from Continuing Operations | $7.10M | $16.20M | $5.50M | $97.50M | $50.50M |
| Minority Interests | $500,000.00 | $700,000.00 | $500,000.00 | $2.90M | $900,000.00 |
| Net Income to Parent Company | $6.60M | $15.50M | $5.00M | $94.60M | $49.60M |
| Net Income to Common Stockholders | $6.60M | $15.50M | $5.00M | $94.60M | $49.60M |
| Basic EPS | $0.20 | $0.45 | $0.14 | $2.57 | $1.39 |
| Diluted EPS | $0.19 | $0.44 | $0.14 | $2.54 | $1.37 |
| -Less:Write Off | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $3.66B | $3.74B | $3.83B | $3.85B | $3.85B |
| Total Current Assets | $1.66B | $1.71B | $1.80B | $1.79B | $1.79B |
| Cash and Cash Equivalents & Short-Term Investments | $184.90M | $282.40M | $373.60M | $398.00M | $398.00M |
| -Cash and Cash Equivalents | $184.90M | $282.40M | $373.60M | $368.90M | $368.90M |
| -Short Term Investments | $0.00 | $0.00 | $0.00 | $29.10M | $29.10M |
| Receivables | $680.10M | $652.20M | $597.00M | $609.40M | $609.40M |
| -Accounts Receivable | $577.40M | $573.40M | $597.00M | $609.40M | $609.40M |
| -Taxes Receivable | $102.70M | $78.80M | – | – | – |
| Prepaid Assets | $32.10M | $33.50M | $31.10M | $50.90M | $50.90M |
| Inventory | $561.70M | $595.90M | $553.10M | $521.00M | $521.00M |
| Other Current Assets | $196.40M | $147.80M | $245.30M | $189.10M | $189.10M |
| Total Non-Current Assets | $2.01B | $2.02B | $2.03B | $2.07B | $2.07B |
| Net PPE | $314.00M | $306.40M | $293.00M | $286.00M | $286.00M |
| -Gross PPE | $406.30M | $392.70M | $377.00M | $367.00M | $367.00M |
| -Accumulated Depreciation | -$92.30M | -$86.30M | -$84.00M | -$81.00M | -$81.00M |
| Goodwill and Other Intangible Assets | $1.35B | $1.37B | $1.40B | $1.43B | $1.43B |
| -Goodwill | $626.20M | $627.80M | $632.10M | $642.40M | $642.40M |
| -Other Intangible Assets | $725.80M | $743.20M | $764.60M | $792.40M | $792.40M |
| Non-Current Deferred Assets | $114.50M | $102.90M | $103.30M | $105.00M | $105.00M |
| Other Non-Current Assets | $227.70M | $244.50M | $236.80M | $241.80M | $241.80M |
| Total Liabilities | $2.72B | $2.76B | $2.80B | $2.75B | $2.75B |
| Total Current Liabilities | $1.30B | $1.35B | $1.40B | $1.37B | $1.37B |
| Payables | $604.10M | $590.10M | $482.60M | $431.10M | $431.10M |
| -Accounts Payable | $493.00M | $506.20M | $482.60M | $431.10M | $431.10M |
| -Total Tax Payable | $111.10M | $83.90M | – | – | – |
| Current Accrued Expenses | $159.20M | $162.70M | $165.60M | $201.60M | $201.60M |
| Current Deferred Liabilities | $254.10M | $300.30M | $359.40M | $325.80M | $325.80M |
| Other Current Liabilities | $285.80M | $297.70M | $396.40M | $413.00M | $413.00M |
| Total Non-Current Liabilities | $1.42B | $1.41B | $1.40B | $1.38B | $1.38B |
| Long Term Debt and Capital Lease Obligation | $949.30M | $942.90M | $939.40M | $938.50M | $938.50M |
| -Long Term Debt | $949.30M | $942.90M | $939.40M | $938.50M | $938.50M |
| Non-Current Deferred Liabilities | $195.50M | $195.70M | $197.00M | $200.70M | $200.70M |
| Employee Benefits | $111.80M | $113.70M | $115.90M | $120.40M | $120.40M |
| Other Non-Current Liabilities | $159.50M | $157.00M | $147.40M | $118.50M | $118.50M |
| Total Equity | $944.10M | $976.50M | $1.03B | $1.10B | $1.10B |
| Stockholders' Equity | $936.20M | $969.20M | $1.02B | $1.10B | $1.10B |
| Capital Stock | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| -Common Stock | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 | $400,000.00 |
| Additional Paid-In Capital | $1.07B | $1.07B | $1.06B | $1.06B | $1.06B |
| Retained Earnings | $119.00M | $112.40M | $96.90M | $91.90M | $91.90M |
| Less: Treasury Stock | -$285.60M | -$251.70M | -$191.10M | -$130.70M | -$130.70M |
| Gains/Losses Not Affecting Retained Earnings | $29.80M | $39.80M | $52.70M | $77.80M | $77.80M |
| Minority Interests | $7.90M | $7.30M | $3.30M | $4.90M | $4.90M |
| Restricted Cash | – | – | – | $18.40M | $18.40M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$47.40M | -$13.60M | $31.70M | $300.70M | $217.50M |
| Net cash flow from continuing operations | -$47.40M | -$13.60M | $31.70M | $300.70M | $217.50M |
| Net Income from Continuing Operations | $7.20M | $16.20M | $5.50M | $97.50M | $50.50M |
| Gain/Loss from Continuing Operations | -$100,000.00 | -$1.10M | -$600,000.00 | $38.80M | -$3.50M |
| Depreciation & Depletion & Amortization | $31.50M | $30.80M | $31.40M | $127.50M | $30.70M |
| Deferred Tax | -$12.30M | $900,000.00 | $1.30M | -$48.10M | -$16.60M |
| Other Non-Cash Items | -$3.60M | $1.70M | $3.10M | $7.10M | $3.50M |
| Change in Working Capital | -$28.10M | -$66.30M | -$12.20M | $65.80M | $154.90M |
| -Change in Receivables | -$6.40M | $23.00M | $3.80M | $25.90M | -$28.10M |
| -Change in Inventory | $31.70M | -$44.10M | -$38.70M | $65.10M | $78.30M |
| -Change in Payables and Accrued Expense | -$13.00M | $22.70M | $30.30M | -$34.20M | $20.10M |
| -Change In Other Working Capital | -$40.40M | -$67.90M | -$7.60M | $9.00M | $84.60M |
| Net cash flow from investing | -$13.20M | -$15.50M | $20.20M | -$97.60M | -$38.60M |
| Net Cash Flow from Continuing Investing Activities | -$13.20M | -$15.50M | $20.20M | -$97.60M | -$38.60M |
| Capital Expenditure | -$12.90M | -$15.30M | -$11.00M | -$61.70M | -$21.80M |
| Net Investment Purchase and Sale | -$400,000.00 | -$300,000.00 | $29.10M | -$12.40M | -$12.40M |
| Net Other Investing Changes | $100,000.00 | $100,000.00 | $2.10M | $1.00M | $1.70M |
| Financing Cash Flow | -$36.00M | -$62.50M | -$62.20M | -$143.90M | -$55.70M |
| Net Cash Flow from Continuing Financing Activities | -$36.00M | -$62.50M | -$62.20M | -$143.90M | -$55.70M |
| Net Common Stock Issuance | -$33.90M | -$60.60M | -$60.40M | -$130.70M | -$51.10M |
| Net Other Financing Charges | -$2.10M | -$1.90M | -$1.80M | -$13.20M | -$4.60M |
| Ending Cash Balance | $184.90M | $282.40M | $373.60M | $387.30M | $387.30M |
| Net Change in Cash | -$96.60M | -$91.60M | -$10.30M | $59.20M | $123.20M |
| Beginning Cash Balance | $282.40M | $373.60M | $387.30M | $311.30M | $262.60M |
| Effect of Exchange Rate Changes | -$900,000.00 | $400,000.00 | -$3.40M | $16.80M | $1.50M |
| Free Cash Flow | -$60.30M | -$28.90M | $20.70M | $239.00M | $195.70M |
| Net Business Purchase and Sale | – | – | – | -$24.50M | -$6.10M |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on DBD.
Sign in to join the discussion.